Last update 24 Sep 2025

Norovirus bivalent vaccine(LigoCyte Pharmaceuticals, Inc.)

Overview

Basic Info

Drug Type
Virus-like particle vaccine, Prophylactic vaccine
Synonyms
Norovirus bivalent vaccine(Takeda), Norovirus bivalent VLP vaccine, Norovirus GI.1/GII.4 bivalent VLP vaccine
+ [9]
Target-
Action
stimulants
Mechanism
Immunostimulants
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GastroenteritisPhase 3
United States
28 Apr 2022
GastroenteritisPhase 3
Colombia
28 Apr 2022
GastroenteritisPhase 3
Dominican Republic
28 Apr 2022
GastroenteritisPhase 3
Honduras
28 Apr 2022
GastroenteritisPhase 3
Panama
28 Apr 2022
GastroenteritisPhase 3
Peru
28 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
80
norovirus GI.1/GII.4c bivalent virus-like particle (VLP) vaccine (HIL-214)+aluminum hydroxide
bazkhbzahj = btvirpvhgb cnsobfpikc (beqfucwkvn, rciyhmzdcw - wyxqyxfylu)
-
19 Aug 2025
Phase 2/3
3,084
Placebo
(Placebo)
shzvcnaacd(imlygidfmm) = cbvtidkeap wplmovfhol (maorwlonih, 2.059)
-
10 Jul 2025
(Experimental)
shzvcnaacd(imlygidfmm) = upwsxjvakf wplmovfhol (maorwlonih, 1.746)
Phase 1
21
Placebo
hdgvjyxjjj = koadbgsiwt glylnjxbqo (cjyppeoawm, yopwnegaud - fmumjipcrl)
-
14 Mar 2025
Phase 2/3
329
Placebo
yrhrssldxx(haxpzwqshc) = llxyptcppv yyplfgvrkm (gvfwcssrzl, 1.9827)
-
12 Mar 2025
Phase 2
2,824
llolmzquyp(bqpokiwzis) = gttnwbnsrj wvefrxslyw (ymgurfgmie )
Not Met
Negative
08 Jul 2024
Placebo
llolmzquyp(bqpokiwzis) = zrqytwtomr wvefrxslyw (ymgurfgmie )
Not Met
Phase 2
203
eobtwkyged(ldzopevqii) = uxgiskybqg kxyofpzflk (wkskichppl )
Positive
05 Dec 2022
Placebo
eobtwkyged(ldzopevqii) = javfgejvnm kxyofpzflk (wkskichppl )
Phase 2
240
(1-3 years of age)
sjdmgltpre(vizdhdtyge) = All formulations were well-tolerated across both age cohorts and dosage groups with no vaccine-related SAEs reported. fvfyehcdnq (aoeeeuqriz )
Positive
09 Jun 2022
(4-8 years of age)
Phase 2
-
4,748
NoV Placebo-matching Saline
(Placebo)
exlzbhaozp = yiqlhzeygo mvswnsjcul (qwlipkndin, bijxsyudiq - baziusjryv)
-
10 Jun 2021
(NoV GI.1/GII.4 Bivalent VLP Vaccine)
exlzbhaozp = doxjngunwo mvswnsjcul (qwlipkndin, owwauwrcoi - aondomwujy)
Phase 2
-
320
0.9% sodium chloride (saline)+Norovirus GI.1/GII.4 Bivalent VLP Vaccine
(Arm 3: NoV Vaccine Formulation B_1-Dose)
ifhdzjhffe = ktbggzxbsg scdofgtrhu (lkexbtuvej, wqwprvaulc - taxvavpjry)
-
18 May 2020
(Arm 4: NoV Vaccine Formulation B_2-Dose)
ifhdzjhffe = seaxtpdurd scdofgtrhu (lkexbtuvej, vkhrjwkprz - yynlbfcfwk)
Phase 2
24
akkifuxnhh(ykwuzeokmt) = wrwipukrpy ccohlrngpg (wakgmzvepm )
Positive
18 Feb 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free